[1] American Academy of Otolaryngology. Position Statement :
Otolaryngologists and the COVID-19 Pandemic.
https://www.entnet.org/content/aao-hns-position-statement-otolaryngologists-and-covid-19-pandemic
Accessed 7th April 2020.
[2]: Jensen AR, Nellemann HM, Overgaard J. Tumor progression in
waiting time for 116 radiotherapy in head and neck cancer. Radiother
Oncol. 2007;84(1):5-10. 117 doi:10.1016/j.radonc.2007.04.001
[3]: Wyatt RM, Beddoe AH, Dale RG. The effects of delays in
radiotherapy treatment on tumour control. Phys Med Biol. 2003;48:139–55
[4]: Murphy CT, Galloway TJ, Handorf EA, et al. Survival impact of
increasing time to treatment initiation for patients with head and neck
cancer in the United States. J Clin Oncol. 2016;34:169–78.
[5]: Coca-Pelaz-A, Takes RP, Hutcheson K et al. Head and Neck
Cancer: A review of the impact of treatment delay on outcome.
Adv Ther. 2018
Feb;35(2):153-160. doi: 10.1007/s12325-018-0663-7
[6]: Schutte HM, Heutink F, Wellenstein DJ et al. Impact of Time to
Diagnosis and Treatment in Head and Neck Cancer: A Systematic review.
Otolaryngol Head
Neck Surg. 2020 Feb 25:194599820906387. doi: 10.1177/0194599820906387
[7]: DeGraff LH, Platek AJ, Iovoli AJ et al. The effect of time
between diagnosis and initiation of treatment on outcomes in patients
with head and neck squamous cell carcinoma.
Oral Oncol. 2019
Sep;96:148-152. doi: 10.1016/j.oraloncology.2019.07.021.
[8]: COVID-19: Elective Case Triage Guidelines for Surgical Care.
https://www.facs.org/covid-19/clinical-guidance/elective-case. Accessed
7th April 2020
[9]: Canadian Association of Head & Neck Surgical Oncology (CAHNSO)
guidelines for management of Head & Neck Cancer during the COVID-19
Pandemic. Accessed 7th April 2020.
[10]: Mapping 2019-nCOV.
https://systems.jhu.edu/research/public-health/ncov/. Accessed 7th
April 2020.
[11]: Covid-19 projections assuming full social distancing through
May 2020. https://covid19.healthdata.org/united-states-of-america/texas.
Accessed 11th April 2020
[12]: MD Anderson Head and Neck Surgery Treatment Guidelines
Consortium. Head and neck surgical oncology in the time of a pandemic:
Subsite-specific triage guidelines during COVID-19. Authorea .
April 2020
[13]: Shellenberger TD, Weber RS. Multidisciplinary Team Planning
for Patients with Head and Neck Cancer. Oral Maxillofac Surg Clin North
Am 2018 Nov;30(4):435-444. doi: 10.1016/j.coms.2018.06.005
[14]: S Lei, Jiang F, Su W et al. Clinical characteristics and
outcomes of patients undergoing surgeries during the incubation period
of COVID-19. EClinicalMedicine (2020).
https://doi.org/10.1016/j.eclinm.2020.100331
[15]: Gabrysz-Forget F, Tabet P, Rahal A, et al. Free versus
pedicled flaps for reconstruction of head and neck cancer defects: a
systematic review. 2019. J Otolaryngol head Neck Surg. 48(13): doi:
10.1186/s40463-019-0334-y
[16]: Hanasono MM, Friel MT, Klem C, et al. Impact of reconstructive
microsurgery in patients with advanced oral cavity cancers. Head Neck
2009;31: 1289–1296.
[17]: Kozin ED, Sethi RK, Herr M et al. Comparison of Perioperative
Outcomes between the Supraclavicular Artery Island Flap and
Fasciocutaneous Free flap. Otolaryngo Head Neck Surg 2016
Jan;154(1):66-72
[18]: Corbitt C, Skoracki RJ, Yu P, Hanasono MM. Free flap failure
in head and neck reconstruction. 2014. Head Neck 36(10):1440-5.
[19]: Kovatch KJ, Hanks JE, Steven JR and CL Stucken. Current
practices in microvascular reconstruction in otolaryngology-head and
neck surgery. Laryngoscope. 2019. 129:138-145.
[20]: Leiser Yoav, Barak M, Ghantous Y, et al. Indications for
elective tracheostomy in reconstructive surgery in patients with oral
cancer. 2017. J Craniofac Surg. 28(1): e18-22.
[21]: Tay JK, Khoo MLC and WS Loh. Surgical Considerations for
Tracheostomy During the COVID-19 Pandemic. 2020. JAMA Otolaryngol Head
Neck Surg. Doi:10.100./jamaoto.2020.0764
[22]: World Health Organization. (2020). Laboratory testing for
coronavirus disease 2019 (COVID-19) in suspected human cases: interim
guidance, 2 March 2020. World Health
Organization. https://apps.who.int/iris/handle/10665/331329. Accessed
7th April 2020
[23]: Wang W, Xu Y, Gao R et al. Detection of SARS-CoV-2 in
Different Types of Clinical Specimens. JAMA 2020 Mar 11.
Doi:10.1001/jama.2020.3786
[24]: Chen X, Liu J, Li N et al. Otolaryngology providers must be
alert for mild and asymptomatic COVID-19 patients. JAMA Oto.
https://www.entnet.org/content/oto-journal-covid-19-accepted-papers
[25]: Workman AD, Welling DB, Carter BS, et al. Endonasal
instrumentation and aerosolization risk in the era of COVID-19:
simulation, literature review, and proposed mitigation strategies. 2020.
Int Forum Allergy Rhinol. Doi: 10.1002/alr.22577.
[26]: Maria SA, Fabiana A, Biglioli F, Giovanni F. Role of
management of a head and neck department during the COVID-19 Outbreak in
Lombardy. JAMA Oto.
https://www.entnet.org/content/oto-journal-covid-19-accepted-papers
[27]: Kligerman MP, Vukkadal N, Tsang R et al. Managing the Head and
Neck Cancer Patient with Tracheostomy or Laryngectomy During the
COVID-19 Pandemic. Head & Neck. https://authorea.com/inst/20973
[28]: Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol
generating procedures and risk of transmission of acute respiratory
infections to healthcare workers: A systematic review. PloS
One.2012;7(4)
[29]: Chan JYK, Wong EWY, Lam W. Practical Aspects of
Otolaryngologic Clinical Services During the 2019 Novel Coronavirus
Epidemic: An Experience in Hong Kong. JAMA Otolaryngology– Head & Neck
surgery. 2020. Mar 20. Doi:10.1001/jamaoto.2020.0488
[30]: Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2
infection: a nationwide analysis in China. Lancet
Oncol. 2020;21(3):335-337.
[31]: Bersanelli M. Controversies about COVID-19 and anticancer
treatment with immune checkpoint inhibitors. Immunotherapy. 2020 Mar 26
[32]: Sun X, Roudi R, Dai T et al. Immune-related adverse events
associated with programmed cell death protein-1 and programmed cell
death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA
systematic review and meta-analysis. BMC Cancer. 2019 Jun 10;19(1):558.
[33]: Mehta P, McAuley DF, Brown M et al. COVID-19: consider
cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar
28;395(10229):1033-1034.
[34]: Thomson DJ, Palma D, Guckenberger M et al. Practice
recommendations for risk-adapted head and neck cancer radiotherapy
during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J
Radiat Oncol Biol Phys.
https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information/Journal-Articles
[35]: Rosenthal DI. Consequences of mucositis-induced treatment
breaks and dose reductions on head and neck cancer treatment outcomes. J
Support Oncol 2007 Oct;5(9 Suppl 4):23-32
[36]: Patel RJ et al. Early Institutional Head and Neck Oncologic
and Microvascular Surgery Practice Patterns Across the united States
during the SARS-CoV-2 (COVID-19) Pandemic. Authorea . April 2020
[37]: Parsons JT, Mendenhall WM, Stringer SP et al. Squamous cell
carcinoma of the oropharynx: surgery, radiation therapy, or both.
Cancer. 2002;94(11):2967–80
[38]:
COVID-19:
Recommendations for Management of Elective Surgical
Procedures. https://www.facs.org/covid-19/clinical-guidance.
Accessed 7th April 2020
[39]: Stay Home, Work Safe Order.
https://www.readyharris.org/Stay-Home. Accessed 7th April 2020
[40]: TMB Passes Emergency Rules to Enforce Gov. Abbott’s Executive
Order GA-09
http://www.tmb.state.tx.us/dl/27277A3D-2F5E-1395-E868-98D48D432C1A.
Accessed 7th April 2020
[41]: Information for Travelers Impacted by Governor Abbott’s
Executive Order Mandating 14-Day Quarantine for Travelers Coming into
Texas by Air and Road. https://www.dps.texas.gov/COVIDtravel/ Accessed
7th April 2020
[42]: Governor Abbott Issues Executive Order Implementing Essential
Services And Activities Protocols.
https://gov.texas.gov/news/post/governor-abbott-issues-executive-order-implementing-essential-services-and-activities-protocols.
Accessed 7th April 2020